WASHINGTON, D.C. – “The Global Alzheimer’s Platform Foundation (GAP) enthusiastically welcomes Bill Gates and his team to the fight against Alzheimer’s disease. This epidemic, which affects millions of people worldwide, is growing exponentially and requires new thinking and investment to begin to stem that tide. We at Global Alzheimer’s Platform Foundation are focused on disrupting the Alzheimer’s clinical trial system by collaborating with our 59 (and growing) GAP-Net research sites to reduce time-to-trial by over 50 percent. Faster trials mean that therapies can get to market more quickly and to those who desperately need them. We thank Mr. Gates’ for his commitment to finding treatments for the 44 million people worldwide with Alzheimer’s and related dementia – and the millions more who will be diagnosed in the years ahead. The Alzheimer’s research community welcomes Mr. Gates’ involvement, and we’re proud to have been a part of his research into the disease. The future for Alzheimer’s research is brighter today and we continue to work tirelessly on behalf of all affected.”
Read the full release here.